SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kopran’s arm gets process patent for API product

13 Dec 2021 Evaluate

Kopran’s arm has received process patent for API product. The Indian Patent office has granted Process Patent for 20 years to Kopran Research Laboratories, Wholly owned Subsidiary of the Company for the Active Pharmaceutical Ingredient (API) product NITROXOLINE, for the invention titled ‘improved, cost effective process for producing NITROXOLINE’.

Kopran is engaged primarily in pharmaceuticals business.

Kopran Share Price

193.20 -4.85 (-2.45%)
25-Jun-2026 11:56 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1878.55
Dr. Reddys Labs. 1354.80
Cipla 1442.05
Zydus Lifesciences 1100.00
Lupin 2374.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: